Injectable hydrogel with antimicrobial and anti-inflammatory properties for postoperative tumor wound care.
Xinyun LiDandan XingYangjing BaiYangrui DuShiying LangKaijun LiJun XiangGongyan LiShan LiuPublished in: Biomedical materials (Bristol, England) (2024)
Clinically, tumor removal surgery leaves irregularly shaped wounds that are susceptible to bacterial infection and further lead to excessive inflammation. Injectable hydrogel dressings with antimicrobial and anti-inflammatory properties have been recognized as an effective strategy to care for postoperative tumor wounds and prevent recurrence in recent years. In this work, we constructed a hydrogel network by ionic bonding interactions between quaternized chitosan (QCS) and epigallocatechin gallate (EGCG)-Zn complexes which were coordinated by EGCG and zinc ions. Because of the synergistic effect of QCS and EGCG-Zn, the hydrogel exhibited outstanding antimicrobial capacity (>99.9% inhibition), which could prevent infections caused by Escherichia coli and Staphylococcus aureus . In addition, the hydrogel was able to inhibit the growth of mice breast cancer cells (56.81% survival rate within 72 h) and reduce inflammation, which was attributed to the sustained release of EGCG. The results showed that the hydrogel was effective in inhibiting tumor recurrence and accelerating wound closure when applied to the postoperative tumor wounds. This study provided a simple and reliable strategy for postoperative tumor wound care using antimicrobial and anti-inflammatory injectable dressings, confirming their great potential in the field of postoperative wound dressings.
Keyphrases
- wound healing
- staphylococcus aureus
- hyaluronic acid
- drug delivery
- anti inflammatory
- patients undergoing
- tissue engineering
- healthcare
- escherichia coli
- quality improvement
- type diabetes
- minimally invasive
- pain management
- breast cancer cells
- cancer therapy
- coronary artery disease
- cystic fibrosis
- body mass index
- climate change
- chronic pain
- multidrug resistant
- acute coronary syndrome
- signaling pathway
- percutaneous coronary intervention
- metabolic syndrome
- methicillin resistant staphylococcus aureus
- affordable care act
- water soluble